An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
Key Details
- 1The FISH&CHIPS study involved 7,836 patients who underwent AI-derived FFR-CT analysis from an initial 90,553 receiving CCTA.
- 2Lower FFR-CT values correlated with significantly increased rates of MI, cardiovascular death, and all-cause mortality independent of traditional risk factors.
- 3Patients with severely reduced FFR-CT had a four-fold risk of heart attack and triple risk of death versus those with normal values.
- 4The FFR-CT AI analysis (by HeartFlow) provided additive prognostic value over classical cardiovascular risk scores.
- 5This is the first large-scale evidence of FFR-CT's independent prognostic power in stable CAD.
- 6Study funded by UK MRC; HeartFlow provided analysis but did not fund or direct the study.
Why It Matters
This research demonstrates real-world prognostic utility for AI-based imaging tools in cardiovascular risk prediction, supporting expanded adoption of AI-enhanced CT in personalized patient management and reducing unnecessary procedures.
Source
EurekAlert
Related News
•EurekAlert
AI Tool Predicts Risks for Cancer Patients After Heart Attack
A new AI-powered risk prediction model assists clinicians in treating cancer patients following a heart attack by combining oncology and cardiovascular data.
•EurekAlert
AI-Supported Mammography Reduces Advanced Breast Cancer in Landmark Swedish Trial
AI-supported mammography screening reduces advanced breast cancer rates and improves early detection, according to the largest randomized controlled trial to date.
•EurekAlert
Large Language Models Rival Physicians in Complex Lung Cancer Decisions
A real-world study reveals that large language models (LLMs) can match or exceed human physicians' performance in challenging lung cancer case decision-making, especially for rare cases.